Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Elite provider by MediFind in the treatment of Melanoma. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Dr. Anna L. Chien is Associate Professor and Vice-Chair of Quality, Safety, and Service for the Department of Dermatology at the Johns Hopkins School of Medicine. She is the medical director of the Howard County Dermatology Practice and directed the department’s Cutaneous Translational Research Program for over ten years. Her clinical interests include skin aging, photoprotection, rosacea, and general dermatology. Dr. Chien earned her medical degree from the University of Chicago Pritzker School of Medicine. She completed a transitional-year program at St. Joseph Mercy Hospital and a dermatology residency with the University of Michigan Health System. She speaks English. Dr. Chien is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Acne, Rosacea, Sunburn, and Pustules.

Dr. Farah Succaria is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. She earned her medical degree from the American University of Beirut, where she also completed her dermatology residency. She next pursued Dermatopathology fellowship at Boston University. After fellowship completion, Dr. Succaria returned to Lebanon and founded a mobile dermatology clinic as part of a non-government organization empowering women to help refugees and displaced children. She then came back to Johns Hopkins and completed a postdoctoral dermatology research fellowship. She is also member of the Taube lab team and is actively involved in research with a main focus on immune checkpoint inhibitors, and the role of the tumor microenvironment in various cancers including melanoma and squamous cell carcinoma. Dr. Succaria is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Actinic Keratosis, and Familial Atypical Multiple Mole Melanoma Syndrome.

Dr. Jacobs is the Division Chief of the Division of Breast Cancer Surgery. She also established the Johns Hopkins Medicine Breast Center at Johns Hopkins Howard County Medical Centerl in Columbia. Dr. Jacobs sees patients at both The Johns Hopkins Hospital and at Johns Hopkins Howard County Medical Center. As division chief of breast cancer surgery, Dr. Jacobs leads an expert team of 9 surgeons located at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center in Baltimore; Johns Hopkins Howard County Medical Center; Sibley Memorial Hospital in Washington, D.C.; and Suburban Hospital in Bethesda. She has also initiated new clinics at Johns Hopkins Health Care & Surgery Center - Green Spring Station in Lutherville; Johns Hopkins Howard County Medical Center, and the Skip Viragh Outpatient Center Building in Baltimore. Dr. Jacobs is committed to providing excellent, comprehensive, and patient-centered breast cancer care throughout Johns Hopkins Medicine through close collaboration with oncology, plastic surgery, nursing, rehabilitation medicine, and genetic services. Additionally, Dr. Jacobs has a clinical interest in the treatment of early stage melanoma. She works closely with dermatologists and medical oncologists at Johns Hopkins University and Johns Hopkins Howard County Medical Center to improve awareness and care of melanoma patients by participating in educational programs and clinical research trials. She has also launched research programs in lymphedema and oncoplastic surgery to increase the number of women eligible for breast prevention by combining lumpectomy with plastic surgery techniques to reshape the breast. In addition, Dr. Jacobs is the surgery representative to the National Clinical Trials Network for the Johns Hopkins Executive Committee and the institutional surgery representative to the Translational Breast Cancer Research Consortium. She serves as the Chair of the Cancer Committee at The Johns Hopkins Hospital and at Johns Hopkins Howard County Medical Center, which establishes both programmatic and quality improvement goals for cancer care across the health system on a yearly basis. Dr. Jacobs is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy.

Dr. Crystal Aguh is an Associate Professor of Dermatology and Director of the Ethnic Skin Program at the Johns Hopkins School of Medicine. Dr. Aguh’s area of research focuses primarily on skin conditions that disproportionately impact minority populations, with particular emphasis on scarring alopecia. She has authored two books on hair loss and has published over two dozen peer-reviewed journal articles and given multiple national and international talks. As a result of her work, Dr. Aguh is the recipient of numerous prestigious research awards & grants from the National Institutes of Health (NIH), Skin of Color Society, Johns Hopkins Medical Institutions and the Dermatology Foundation. Dr. Aguh completed her residency at Johns Hopkins School of Medicine, serving as the chief resident in her final year training. She received her undergraduate degree from Duke University and earned her medical degree from the University of Pennsylvania School of Medicine, with honors, earning induction into Alpha Omega Alpha Honor Society. Dr. Aguh is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Autosomal Recessive Hypotrichosis, Graham-Little-Piccardi-Lassueur Syndrome, Trichorrhexis Nodosa, and Alopecia Areata.

Andrew Mener, M.D. has experience treating a wide range of adult hematologic and oncologic disorders, with a particular interest in treating breast, lung, gastrointestinal and hematologic malignancies. He takes great pride in delivering personalized, compassionate care and strives to effectively explain complex treatment options to his patients. He strongly believes in the importance of treating each and every patient as an individual. Learn more at marylandoncology.com. Dr. Mener is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Severe Congenital Neutropenia.

Learn more at marylandoncology.com. Dr. Sastry is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Iron Deficiency Anemia, and Childhood Iron Deficiency Anemia.

Melanie Adams is a Dermatologist in Columbia, Maryland. Dr. Adams is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Actinic Keratosis, Warts, Contact Dermatitis, and Familial Atypical Multiple Mole Melanoma Syndrome.

Edward Lee, M.D. was named one of Baltimore’s “Top Doc’s” by Baltimore Magazine in 2000 and 2002. After receiving additional training in Hematology and Medical Oncology at the University of Maryland in 1984, he remained on faculty until 1997. During his academic career, Dr. Lee was chairman of the training program for five years, started the Bone Marrow Transplant Program at the University of Maryland in 1993, and wrote 50 original articles on leukemia, lymphoma and related diseases. In 1997, Dr. Lee entered private practice as Chief of Hematology and Medical Oncology at Sinai Hospital. Practicing in Columbia since 2001, Dr. Lee treats patients with all forms of cancer, maintaining a particular interest in breast cancer, leukemia, and lymphomas. Learn more at marylandoncology.com. Dr. Lee is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Polycythemia Vera, Paget Disease of the Breast, Breast Cancer, and Primary Lymphoma of the Brain.

As an active participant in the medical community, Mohit Narang, M.D. has served as a primary investigator and research assistant on many trials. During Dr. Narang’s fellowship, he was honored with the invitation to attend the Masterclass in Clinical Oncology at Montecatini, Italy by the European School of Oncology. He holds professional memberships with the American Society of Clinical Oncology, American Society of Hematology, as well as the European Society of Medical Oncology. Learn more at marylandoncology.com. Dr. Narang is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Multiple Myeloma, Agranulocytosis, Paget Disease of the Breast, Thrombocytopenia, and Bone Marrow Transplant.

Christina Clarke is a Dermatologist in Columbia, Maryland. Dr. Clarke is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Contact Dermatitis, Intertrigo, Melanoma, and Actinic Keratosis. Dr. Clarke is currently accepting new patients.

Ari Elman is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Elman has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Small Cell Lung Cancer (SCLC), and Myelodysplastic Syndrome (MDS). Dr. Elman is currently accepting new patients.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

Cheryl Bansal is a Dermatologist in Columbia, Maryland. Dr. Bansal is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Trichoepithelioma, Multiple Familial Trichoepithelioma, Syringocystadenoma Papilliferum, and Syringoma. Dr. Bansal is currently accepting new patients.

Nicholas Girardi is a Dermatologist in Ellicott City, Maryland. Dr. Girardi is rated as an Advanced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Giant Congenital Nevus, Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Fetal Cystic Hygroma. Dr. Girardi is currently accepting new patients.

Smitha Kuppalli is a Dermatologist in Ellicott City, Maryland. Dr. Kuppalli is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Giant Congenital Melanocytic Nevus, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Neurocutaneous Melanosis. Dr. Kuppalli is currently accepting new patients.

Susan Mclaughlin is a Dermatologist in Elkridge, Maryland. Dr. Mclaughlin is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Melanoma, Giant Congenital Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, and Giant Congenital Melanocytic Nevus. Dr. Mclaughlin is currently accepting new patients.

Ife Rodney is a Dermatologist in Fulton, Maryland. Dr. Rodney is rated as an Advanced provider by MediFind in the treatment of Melanoma. Her top areas of expertise are Trichorrhexis Nodosa, Comedones, Autosomal Recessive Hypotrichosis, and Keloids.

Dan Kunaprayoon is a Radiation Oncologist in Columbia, Maryland. Dr. Kunaprayoon is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Breast Cancer, and Pleuropulmonary Blastoma.

Stuart Selonick is a Hematologist Oncology specialist and a Hematologist in Columbia, Maryland. Dr. Selonick is rated as an Experienced provider by MediFind in the treatment of Melanoma. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Idiopathic Neutropenia, and Lung Cancer. Dr. Selonick is currently accepting new patients.